ÐÓ°ÉÔ­´´

Spore Biotechnologies logo

Spore Biotechnologies

Startups icon ÐÓ°ÉÔ­´´ Score 48 Startups icon Startups

1

Founding Rounds

4

Investors

$8.63m

Money raised

Overview

Spore Biotechnologies demonstrates strong potential by addressing a significant need in the FMCG manufacturing sector. Their real-time pathogen detection devices offer clear advantages over traditional methods, which typically involve delayed lab results. By providing instant detection, Spore Biotechnologies helps prevent the distribution of contaminated products, reduces costly recalls, and enhances consumer safety. Based in Paris and backed by notable investors, the company is well-positioned to leverage IoT advancements to revolutionize quality control in FMCG factories. This strategy not only emphasizes efficiency but also upholds critical health and safety standards, giving Spore a competitive edge.
  • Website:
  • Business model: b2b
  • Company size: 1 - 11 employees
  • Headquarters: Paris, France
  • Founded: 2022
  • Social accounts:

Investors (4)

Local Globe logo Local Globe

Climate Tech & Green Tech, Health Tech, Edtech, FinTech, Crypto & web3, ...

Details
No Label Ventures logo No Label Ventures

Manufacturing, Internet of Things

Details

View all investors.

Join 23,000+ founders, operators and investors.

Fonding

Fonding series

Funding Series Analysis

The company Spore Biotechnologies has raised a total of $8.63m in funding over 1 rounds.

Key Insights:

  • Pre Seed: $8.63m
Spore Biotechnologies logo
Spore Biotechnologies Pre Seed (2023, $8M) $8.63m